vimarsana.com

Page 38 - ஸ்டான்போர்ட் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Male Clinicians as Allies in Women s Leadership: What Your Female Peers Want You to Know

Male Clinicians as Allies in Women s Leadership: What Your Female Peers Want You to Know
practicalpainmanagement.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from practicalpainmanagement.com Daily Mail and Mail on Sunday newspapers.

CRISPRa identifies potassium channels as neuronal entry factors and druggable targets for SARS-CoV-2

CRISPRa identifies potassium channels as neuronal entry factors and druggable targets for SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes various symptoms that go beyond respiratory problems. Neurological, cardiac, and other issues can emerge during infection and after recovery in long COVID, suggesting SARS-CoV-2 invades several organs. However, how SARS-CoV-2 invades the brain whether directly or indirectly remains under investigation. New research led by Le Cong of Stanford University School of Medicine in California indicates that the KCNA6 potassium channel may help with viral entry and promote infection. In addition, KCNA6 is highly expressed in OLIG2+ neuronal cells, which has been shown to be suspectable to SARS-CoV-2 in the olfactory neuroepithelium. This area appears to contribute to loss of smell commonly observed during infection.

Bay Area Lyme Foundation Selects National Winners of the 2021 Emerging Leader Awards to Advance Research for the Diagnosis and Treatment of Lyme Disease

Bay Area Lyme Foundation Selects National Winners of the 2021 Emerging Leader Awards to Advance Research for the Diagnosis and Treatment of Lyme Disease
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.